Key facts
- This page summarizes David R. Dantzker's Form 4 filing for SURMODICS INC (SRDX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2021, 11:29.
David R. Dantzker - 30 Jun 2021 Form 4 Insider Report for SURMODICS INC (SRDX)
- Reporting relationship
- Director
- Issuer ticker
- SRDX
- Reported as of
- 30 Jun 2021
- Net transaction value
- +$18,716
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2021, 11:29:04 UTC
- Next SEC filing
- 04 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Manders, on behalf of David R. Dantzker
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David R. Dantzker filed Form 4 for SURMODICS INC (SRDX) on 02 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$18,716.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRDX
transaction
Common Stock
Award
- Transaction value
- $18,716
- Shares
- +345
- Change %
- +1.1%
- Price
- $54.25
- Shares after
- 30,484
- Date
- 30 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reporting person elected to receive vested deferred stock units (DSUs) in lieu of quarterly cash retainer payments. The DSUs are settled in shares of the issuer's common stock as described below.
Footnote F2
The amount beneficially owned includes 10,610 restricted stock units (RSUs) that vest on service-based vesting dates and 14,689 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends. Remarks: